APA (7th ed.) Citation

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health. (2018). Examining FDA's generic drug and biosimilar user fee programs: Hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, March 2, 2017. U.S. Government Publishing Office.

Chicago Style (17th ed.) Citation

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health. Examining FDA's Generic Drug and Biosimilar User Fee Programs: Hearing Before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, First Session, March 2, 2017. Washington: U.S. Government Publishing Office, 2018.

MLA (9th ed.) Citation

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health. Examining FDA's Generic Drug and Biosimilar User Fee Programs: Hearing Before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, First Session, March 2, 2017. U.S. Government Publishing Office, 2018.